126 related articles for article (PubMed ID: 9198288)
1. Hyperdynamic circulation in prehepatic portal hypertension: role of tumor necrosis factor-alpha.
Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Wu SL; Tai CC; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Mar; 59(3):145-50. PubMed ID: 9198288
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats.
Lopez-Talavera JC; Merrill WW; Groszmann RJ
Gastroenterology; 1995 Mar; 108(3):761-7. PubMed ID: 7875478
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats.
Lopez-Talavera JC; Cadelina G; Olchowski J; Merrill W; Groszmann RJ
Hepatology; 1996 Jun; 23(6):1616-21. PubMed ID: 8675185
[TBL] [Abstract][Full Text] [Related]
4. Evidence against a role for endotoxin in the hyperdynamic circulation of rats with prehepatic portal hypertension.
Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Lu RH; Wu SL; Chan CC; Tai CC; Lai IN; Lee SD
J Hepatol; 1999 Jun; 30(6):1105-11. PubMed ID: 10406190
[TBL] [Abstract][Full Text] [Related]
5. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
6. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.
Wang JJ; Gao GW; Gao RZ; Liu CA; Ding X; Yao ZX
World J Gastroenterol; 2004 Mar; 10(5):689-93. PubMed ID: 14991939
[TBL] [Abstract][Full Text] [Related]
7. Hyperdynamic circulation of cirrhotic rats with ascites: role of endotoxin, tumour necrosis factor-alpha and nitric oxide.
Chu CJ; Lee FY; Wang SS; Lu RH; Tsai YT; Lin HC; Hou MC; Chan CC; Lee SD
Clin Sci (Lond); 1997 Sep; 93(3):219-25. PubMed ID: 9337636
[TBL] [Abstract][Full Text] [Related]
8. An animal study of portal hypertension.
Lay CS; Yang CM; Tsai YT; Chen HI; Simchon S; Chien S
Zhonghua Yi Xue Za Zhi (Taipei); 1989 Jul; 44(1):19-24. PubMed ID: 2819564
[TBL] [Abstract][Full Text] [Related]
9. Bile acids do not mediate the hyperdynamic circulation in portal hypertensive rats.
Genecin P; Polio J; Colombato LA; Ferraioli G; Reuben A; Groszmann RJ
Am J Physiol; 1990 Jul; 259(1 Pt 1):G21-5. PubMed ID: 2372062
[TBL] [Abstract][Full Text] [Related]
10. Factors mediating the hemodynamic effects of tumor necrosis factor-alpha in portal hypertensive rats.
Muñoz J; Albillos A; Pérez-Páramo M; Rossi I; Alvarez-Mon M
Am J Physiol; 1999 Mar; 276(3):G687-93. PubMed ID: 10070045
[TBL] [Abstract][Full Text] [Related]
11. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the hemodynamic effects of tumor necrosis factor alpha factor in rats with portal hypertension using the radioactive microsphere technique].
Pérez-Páramo M; Muñoz J; Albillos A; Rossi I; Alvarez-Mon M; Ortiz Berrocal J
Rev Esp Med Nucl; 1998; 17(4):294-301. PubMed ID: 9721346
[TBL] [Abstract][Full Text] [Related]
13. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats.
Lee FY; Wang SS; Tsai YT; Lin HJ; Lin HC; Chu CJ; Wu SL; Tai CC; Lee SD
J Hepatol; 1997 Mar; 26(3):687-93. PubMed ID: 9075678
[TBL] [Abstract][Full Text] [Related]
14. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats.
Cao H; Wu Z; Zhou J; Chen Z; Kuang Y
Chin Med J (Engl); 1999 Jun; 112(6):516-9. PubMed ID: 11601330
[TBL] [Abstract][Full Text] [Related]
15. Na restriction blunts expansion of plasma volume and ameliorates hyperdynamic circulation in portal hypertension.
Genecin P; Polio J; Groszmann RJ
Am J Physiol; 1990 Sep; 259(3 Pt 1):G498-503. PubMed ID: 2399990
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
López-Talavera JC; Levitzki A; Martínez M; Gazit A; Esteban R; Guardia J
J Clin Invest; 1997 Aug; 100(3):664-70. PubMed ID: 9239414
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic studies and esophageal morphometric analyses in portal hypertensive rats with left adrenal vein ligation.
Lee FY; Wang SS; Tsai YT; Chang FY; Lin HC; Hou MC; Chu CJ; Wu SL; Tai CC; Lee SD
Scand J Gastroenterol; 1997 Jul; 32(7):725-30. PubMed ID: 9246715
[TBL] [Abstract][Full Text] [Related]
18. [Hyperdynamic status in a partial portal vein ligated (PVL) rat's portal hypertension model].
Wang CT; Kuang YL; Chen ZP
Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):573-5. PubMed ID: 7720436
[TBL] [Abstract][Full Text] [Related]
19. Role of endotoxaemia in hyperdynamic circulation in rats with extrahepatic or intrahepatic portal hypertension.
Lee FY; Wang SS; Yang MC; Tsai YT; Wu SL; Lu RH; Chan CY; Lee SD
J Gastroenterol Hepatol; 1996 Feb; 11(2):152-8. PubMed ID: 8672761
[TBL] [Abstract][Full Text] [Related]
20. Preventive effect of preoperative portal vein ligation on endotoxin-induced hepatic failure in hepatectomized rats is associated with reduced tumour necrosis factor alpha production.
Yachida S; Ikeda K; Kaneda K; Goda F; Maeba T; Maeta H
Br J Surg; 2000 Oct; 87(10):1382-90. PubMed ID: 11044165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
